Perel Nimrod, Asher Elad, Taha Luoay, Levy Nir, Steinmetz Yoed, Karameh Hani, Karmi Mohammad, Maller Tomer, Harari Emanuel, Dvir Danny, Glikson Michael, Carasso Shemy, Shuvy Mony
Jesselson Integrated Heart Centre, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University, 12, Shmu'el Bait, P.O. 3235, Jerusalem 9103102, Israel.
The Azrieli Faculty of Medicine, Bar Ilan University, Zefat 1311502, Israel.
J Clin Med. 2022 Sep 23;11(19):5617. doi: 10.3390/jcm11195617.
Introduction Patients suffering from cardiogenic shock (CS) and mitral regurgitation (MR) demonstrate worse prognosis, with higher mortality rates. We sought to evaluate the effectiveness of urgent valve intervention of the mitral valve, using transcatheter edge-to-edge repair (TEER) procedures in patients presenting with CS in a tertiary Intensive Coronary Care Unit (ICCU). Methods and Results Patients with unremitting CS and severe MR were selected for urgent TEER. Baseline clinical and echocardiographic characteristics were recorded, as well as procedural success (MR severity and hemodynamics), and 30-days and 6-month mortality. Urgent TEER was done in 13 patients, whose average age was 70 years; 12 (92%) of the patients were male. All 13 patients had suffered previous ischemic heart disease-12 (92%) with either acute severe MR or worsening of previously known MR by an acute ischemic event. Using the SCAI criteria, 8 patients (61%) were classified as 'E' (Extreme) category; 4 (31%) were classified as 'C'. At 30 days, 12 out of the 13 patients survived (corresponding to an 8% mortality rate); all of those 12 patients remained alive at 6 months post-admission/procedure. Conclusions The use of TEER was associated with greater 30-day and 6-month survival rates, compared to the worldwide mortality rates of patients admitted with CS. This finding may change the previous paradigm that CS and MR are associated with the worst outcome, and we might be able to offer these patients a safe and effective therapeutic option.
患有心源性休克(CS)和二尖瓣反流(MR)的患者预后较差,死亡率较高。我们试图评估在三级重症冠心病监护病房(ICCU)中,对出现CS的患者使用经导管缘对缘修复(TEER)手术进行二尖瓣紧急瓣膜干预的有效性。
选择患有持续性CS和严重MR的患者进行紧急TEER。记录基线临床和超声心动图特征,以及手术成功率(MR严重程度和血流动力学)、30天和6个月死亡率。13例患者接受了紧急TEER,平均年龄70岁;其中12例(92%)为男性。所有13例患者既往均患有缺血性心脏病,其中12例(92%)伴有急性严重MR或因急性缺血事件导致既往已知的MR恶化。根据SCAI标准,8例患者(61%)被归类为“E”(极重度)类别;4例(31%)被归类为“C”类别。30天时,13例患者中有12例存活(死亡率为8%);这12例患者在入院/手术后6个月均存活。
与全球CS患者的死亡率相比,TEER的使用与更高的30天和6个月生存率相关。这一发现可能会改变之前认为CS和MR与最差预后相关的模式,我们或许能够为这些患者提供一种安全有效的治疗选择。